Amperos Health Raises $16M Series A Led by Bessemer Venture Partners

Why It Matters

The solution tackles a $262 billion revenue loss from denied claims, offering providers a scalable, cost‑effective way to improve cash flow and reduce staffing pressures in revenue cycle management.

Key Takeaways

• Amperos raised $16M Series A led by Bessemer Venture Partners.
• Platform uses agentic AI to navigate payer portals and submit claims.
• Clients see up to 50% cost reduction versus traditional vendors.
• Denial resolution speed is five times faster than conventional methods.
• Over 3,000 locations recover nearly $700M annually with the solution.

Pulse Analysis

Healthcare providers lose an estimated $262 billion each year to claim denials, a problem amplified by understaffed revenue cycle teams and increasingly sophisticated payer algorithms. As insurers adopt AI‑driven denial strategies, providers need equally advanced tools to protect their margins. Amperos Health’s agentic AI platform directly addresses this gap by automating the entire denial lifecycle—from portal navigation and insurer outreach to claim correction and appeal drafting—while retaining a human‑in‑the‑loop for complex cases. This hybrid approach delivers measurable financial relief, with early customers reporting up to a 70% reduction in overall denial rates and a 20%‑plus boost in recovered revenue per claim.

The technology leverages proprietary large language models equipped with computer and voice capabilities, enabling the system to act autonomously within payer portals and even place phone calls on behalf of providers. By continuously benchmarking AI performance against seasoned revenue cycle specialists, the platform refines its strategies as payer behaviors evolve. The reported five‑fold acceleration in denial resolution and up to 50% lower collection costs translate into significant operational efficiencies, allowing staff to focus on high‑complexity claims that still require human judgment.

Strategically, the $16 million Series A funding positions Amperos to expand beyond denial management into broader revenue cycle workflows and advanced analytics. Investors such as Bessemer Venture Partners see the venture as a critical infrastructure play in a $1.5 trillion healthcare finance market. For providers, the solution promises not only immediate cash‑flow improvements but also a sustainable competitive advantage in an industry where financial resilience increasingly hinges on technology‑driven automation.

Deal Summary

Amperos Health, an AI-native denial management platform, closed a $16M Series A round on April 22, 2026. The round was led by Bessemer Venture Partners with participation from Uncork Capital and Neo, and will fund expansion of its agentic AI revenue recovery platform.